703 related articles for article (PubMed ID: 20368579)
1. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
[TBL] [Abstract][Full Text] [Related]
2. Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice.
Cao J; Wang S; Wei C; Lin H; Zhang C; Gao Y; Xu Z; Cheng Z; Sun WC; Wang HB
Int Immunopharmacol; 2021 Jan; 90():107137. PubMed ID: 33199235
[TBL] [Abstract][Full Text] [Related]
3. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
[TBL] [Abstract][Full Text] [Related]
4. Regulators of osteoclast differentiation and cell-cell fusion.
Miyamoto T
Keio J Med; 2011; 60(4):101-5. PubMed ID: 22200633
[TBL] [Abstract][Full Text] [Related]
5. Unkeito Suppresses RANKL-Mediated Osteoclastogenesis via the Blimp1-Bcl6 and NF-κB Signaling Pathways and Enhancing Osteoclast Apoptosis.
Fang K; Murakami Y; Kanda S; Shimono T; Dang AT; Ono M; Nishiyama T
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887169
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory Effect of Purpurogallin on Osteoclast Differentiation in Vitro through the Downregulation of c-Fos and NFATc1.
Kim K; Kim TH; Ihn HJ; Kim JE; Choi JY; Shin HI; Park EK
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463002
[TBL] [Abstract][Full Text] [Related]
7. Secretion of a truncated osteopetrosis-associated transmembrane protein 1 (OSTM1) mutant inhibits osteoclastogenesis through down-regulation of the B lymphocyte-induced maturation protein 1 (BLIMP1)-nuclear factor of activated T cells c1 (NFATc1) axis.
Shin B; Yu J; Park ES; Choi S; Yu J; Hwang JM; Yun H; Chung YH; Hong KS; Choi JS; Takami M; Rho J
J Biol Chem; 2014 Dec; 289(52):35868-81. PubMed ID: 25359771
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling.
Park-Min KH; Lee EY; Moskowitz NK; Lim E; Lee SK; Lorenzo JA; Huang C; Melnick AM; Purdue PE; Goldring SR; Ivashkiv LB
J Bone Miner Res; 2013 Jan; 28(1):135-49. PubMed ID: 22893614
[TBL] [Abstract][Full Text] [Related]
9. IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).
Chen Z; Su L; Xu Q; Katz J; Michalek SM; Fan M; Feng X; Zhang P
J Biol Chem; 2015 Dec; 290(50):30163-74. PubMed ID: 26483549
[TBL] [Abstract][Full Text] [Related]
10. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1.
Nakagawa S; Omori K; Nakayama M; Mandai H; Yamamoto S; Kobayashi H; Sako H; Sakaida K; Yoshimura H; Ishii S; Ibaragi S; Hirai K; Yamashiro K; Yamamoto T; Suga S; Takashiba S
Int Immunopharmacol; 2020 Jun; 83():106429. PubMed ID: 32222639
[TBL] [Abstract][Full Text] [Related]
11. Agelasine D suppresses RANKL-induced osteoclastogenesis via down-regulation of c-Fos, NFATc1 and NF-κB.
Kang MR; Jo SA; Yoon YD; Park KH; Oh SJ; Yun J; Lee CW; Nam KH; Kim Y; Han SB; Yu J; Rho J; Kang JS
Mar Drugs; 2014 Nov; 12(11):5643-56. PubMed ID: 25421321
[TBL] [Abstract][Full Text] [Related]
12. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
13. Pax5 Negatively Regulates Osteoclastogenesis through Downregulation of Blimp1.
Yu J; Kim S; Lee N; Jeon H; Lee J; Takami M; Rho J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672551
[TBL] [Abstract][Full Text] [Related]
14. Genetic disruption of Ano5 leads to impaired osteoclastogenesis for gnathodiaphyseal dysplasia.
Liu X; Wang X; Ma X; Li H; Miao C; Tian Z; Hu Y
Oral Dis; 2024 Apr; 30(3):1403-1415. PubMed ID: 36989132
[TBL] [Abstract][Full Text] [Related]
15. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
[TBL] [Abstract][Full Text] [Related]
16. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation.
Nishikawa K; Nakashima T; Hayashi M; Fukunaga T; Kato S; Kodama T; Takahashi S; Calame K; Takayanagi H
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3117-22. PubMed ID: 20133620
[TBL] [Abstract][Full Text] [Related]
17. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T
J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684
[TBL] [Abstract][Full Text] [Related]
18. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells.
Schulze J; Bickert T; Beil FT; Zaiss MM; Albers J; Wintges K; Streichert T; Klaetschke K; Keller J; Hissnauer TN; Spiro AS; Gessner A; Schett G; Amling M; McKenzie AN; Horst AK; Schinke T
J Bone Miner Res; 2011 Apr; 26(4):704-17. PubMed ID: 20939024
[TBL] [Abstract][Full Text] [Related]
20. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
